Table of Contents Global Neurotherapeutic Drugs Sales Market Report 2018 by Manufacturer, Region, Type and Application 1 Neurotherapeutic Drugs Market Overview 1.1 Product Overview and Scope of Neurotherapeutic Drugs 1.2 Classification of Neurotherapeutic Drugs by Product Category 1.2.1 Global Neurotherapeutic Drugs Market Size (Sales) Comparison by Type (2012-2023) 1.2.2 Global Neurotherapeutic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Peripheral Nervous System Disorders (PNS) Disorder 1.2.4 Autonomous Nervous System (ANS) Disorder 1.2.5 Central Nervous System (CNS) Disorders 1.2.6 Other 1.3 Global Neurotherapeutic Drugs Market by Application/End Users 1.3.1 Global Neurotherapeutic Drugs Sales (Volume) and Market Share Comparison by Application (2012-2023) 1.3.2 Hosptical 1.3.3 Drug Stores 1.3.4 Other 1.4 Global Neurotherapeutic Drugs Market by Region 1.4.1 Global Neurotherapeutic Drugs Market Size (Value) Comparison by Region (2012-2023) 1.4.2 North America Neurotherapeutic Drugs Status and Prospect (2012-2023) 1.4.3 Europe Neurotherapeutic Drugs Status and Prospect (2012-2023) 1.4.4 China Neurotherapeutic Drugs Status and Prospect (2012-2023) 1.4.5 Japan Neurotherapeutic Drugs Status and Prospect (2012-2023) 1.4.6 Southeast Asia Neurotherapeutic Drugs Status and Prospect (2012-2023) 1.4.7 India Neurotherapeutic Drugs Status and Prospect (2012-2023) 1.5 Global Market Size (Value and Volume) of Neurotherapeutic Drugs (2012-2023) 1.5.1 Global Neurotherapeutic Drugs Sales and Growth Rate (2012-2023) 1.5.2 Global Neurotherapeutic Drugs Revenue and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Neurotherapeutic Drugs 2.2 Raw Material Analysis of Neurotherapeutic Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Neurotherapeutic Drugs 2.4 Other Costs Analysis of Neurotherapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs 2.6 Manufacturing Process Analysis of Neurotherapeutic Drugs 2.7 Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2017 2.8 Downstream Buyers 3 Global Neurotherapeutic Drugs Players/Suppliers Profiles and Sales Data 3.1 Abbott 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.5 Abbott Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.2 BD 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 BD Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.5 BD Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.3 Novartis AG 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Novartis AG Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.5 Novartis AG Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.4 Johnson & Johnson 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Johnson & Johnson Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.5 Johnson & Johnson Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Pfizer 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Pfizer Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.5 Pfizer Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Sanofi-Aventis 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Sanofi-Aventis Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.5 Sanofi-Aventis Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Biogen 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biogen Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.5 Biogen Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.8 GlaxoSmithKline 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 GlaxoSmithKline Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.5 GlaxoSmithKline Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.9 AstraZeneca Merck 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 AstraZeneca Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 AstraZeneca Merck Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.5 AstraZeneca Merck Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 4 Global Neurotherapeutic Drugs Market Competition by Players 4.1 Global Neurotherapeutic Drugs Sales (K Units) and Market Share (%) of Key Players (2012-2017) 4.1.1 Global Neurotherapeutic Drugs Sales (K Units) and Market Share (%) of Key Players (2012-2017) 4.1.2 Global Neurotherapeutic Drugs Revenue (Million USD) and Share by Players (2012-2017) 4.2 Global Neurotherapeutic Drugs Sales and Revenue by Type 4.1.1 Global Neurotherapeutic Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) 4.1.2 Global Neurotherapeutic Drugs Revenue (Million USD) and Market Share (%) by Type (2012-2017) 4.3 Global Neurotherapeutic Drugs Sales and Revenue by Regions 4.3.1 Global Neurotherapeutic Drugs Sales (K Units) and Market Share (%) by Regions (2012-2017) 4.3.2 Global Neurotherapeutic Drugs Revenue and Market Share (%) by Regions (2012-2017) 4.4 Global Neurotherapeutic Drugs Revenue and Market Share (%) by Regions (2012-2017) 5 North America Neurotherapeutic Drugs (Volume, Value and Sales Price) 5.1 North America Neurotherapeutic Drugs Sales and Value (2012-2017) 5.1.1 North America Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 5.1.2 North America Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 5.1.3 North America Neurotherapeutic Drugs Sales Price Trend (2012-2017) 5.2 North America Neurotherapeutic Drugs Sales Volume and Market Share by Players 5.3 North America Neurotherapeutic Drugs Sales Volume and Market Share by Type 5.4 North America Neurotherapeutic Drugs Sales Volume and Market Share by Application 6 Europe Neurotherapeutic Drugs (Volume, Value and Sales Price) 6.1 Europe Neurotherapeutic Drugs Sales and Value (2012-2017) 6.1.1 Europe Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 6.1.2 Europe Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 6.1.3 Europe Neurotherapeutic Drugs Sales Price Trend (2012-2017) 6.2 Europe Neurotherapeutic Drugs Sales Volume and Market Share by Players 6.3 Europe Neurotherapeutic Drugs Sales Volume and Market Share by Type 6.4 Europe Neurotherapeutic Drugs Sales Volume and Market Share by Application 7 China Neurotherapeutic Drugs (Volume, Value and Sales Price) 7.1 China Neurotherapeutic Drugs Sales and Value (2012-2017) 7.1.1 China Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 7.1.2 China Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 7.1.3 China Neurotherapeutic Drugs Sales Price Trend (2012-2017) 7.2 China Neurotherapeutic Drugs Sales Volume and Market Share by Players 7.3 China Neurotherapeutic Drugs Sales Volume and Market Share by Type 7.4 China Neurotherapeutic Drugs Sales Volume and Market Share by Application 8 Japan Neurotherapeutic Drugs (Volume, Value and Sales Price) 8.1 Japan Neurotherapeutic Drugs Sales and Value (2012-2017) 8.1.1 Japan Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 8.1.2 Japan Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Japan Neurotherapeutic Drugs Sales Price Trend (2012-2017) 8.2 Japan Neurotherapeutic Drugs Sales Volume and Market Share by Players 8.3 Japan Neurotherapeutic Drugs Sales Volume and Market Share by Type 8.4 Japan Neurotherapeutic Drugs Sales Volume and Market Share by Application 9 Southeast Asia Neurotherapeutic Drugs (Volume, Value and Sales Price) 9.1 Southeast Asia Neurotherapeutic Drugs Sales and Value (2012-2017) 9.1.1 Southeast Asia Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 9.1.2 Southeast Asia Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 9.1.3 Southeast Asia Neurotherapeutic Drugs Sales Price Trend (2012-2017) 9.2 Southeast Asia Neurotherapeutic Drugs Sales Volume and Market Share by Players 9.3 Southeast Asia Neurotherapeutic Drugs Sales Volume and Market Share by Type 9.4 Southeast Asia Neurotherapeutic Drugs Sales Volume and Market Share by Application 10 India Neurotherapeutic Drugs (Volume, Value and Sales Price) 10.1 India Neurotherapeutic Drugs Sales and Value (2012-2017) 10.1.1 India Neurotherapeutic Drugs Sales and Growth Rate (2012-2017) 10.1.2 India Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 10.1.3 India Neurotherapeutic Drugs Sales Price Trend (2012-2017) 10.2 India Neurotherapeutic Drugs Sales Volume and Market Share by Players 10.3 India Neurotherapeutic Drugs Sales Volume and Market Share by Type 10.4 India Neurotherapeutic Drugs Sales Volume and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 Global Neurotherapeutic Drugs Market Forecast (2018-2023) 12.1 Global Neurotherapeutic Drugs Sales Volume, Revenue and Price Forecast (2018-2023) 12.1.1 Global Neurotherapeutic Drugs Sales Volume and Growth Rate Forecast (2018-2023) 12.1.2 Global Neurotherapeutic Drugs Revenue and Growth Rate Forecast (2018-2023) 12.1.3 Global Neurotherapeutic Drugs Price and Trend Forecast (2018-2023) 12.2 Global Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 Global Neurotherapeutic Drugs Sales Volume and Growth Rate Forecast by Regions (2018-2023) 12.2.2 Global Neurotherapeutic Drugs Revenue and Growth Rate Forecast by Regions (2018-2023) 12.2.3 North America Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Europe Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 China Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 Japan Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.7 Southeast Asia Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.2.8 India Neurotherapeutic Drugs Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 12.3 Global Neurotherapeutic Drugs Sales Volume, Revenue and Price Forecast by Type (2018-2023) 12.3.1 Global Neurotherapeutic Drugs Sales Forecast by Type (2018-2023) 12.3.2 Global Neurotherapeutic Drugs Revenue Forecast by Type (2018-2023) 12.3.3 Global Neurotherapeutic Drugs Price Forecast by Type (2018-2023) 12.4 Global Neurotherapeutic Drugs Sales Volume Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure Global Market Size (Million USD) Status and Outlook 2012-2023 Table Global Market Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table Neurotherapeutic Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Neurotherapeutic Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Neurotherapeutic Drugs Table Global Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Global Neurotherapeutic Drugs Sales Market Share (%) by Types in 2017 Figure Peripheral Nervous System Disorders (PNS) Disorder Picture Figure Autonomous Nervous System (ANS) Disorder Picture Figure Central Nervous System (CNS) Disorders Picture Table Global Neurotherapeutic Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure Global Sales Market Share (%) of Neurotherapeutic Drugs by Applications in 2017 Figure Hosptical Picture Figure Drug Stores Picture Figure Other Picture Table Global Market Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure North America Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure India Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Global Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) Figure Global Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Table Global Neurotherapeutic Drugs Sales (K Units) of Key Players (2012-2017) Table Global Neurotherapeutic Drugs Sales Share (%) by Players (2012-2017) Figure 2016 Global Neurotherapeutic Drugs Sales Share (%) by Players Figure 2017 Global Neurotherapeutic Drugs Sales Share (%) by Players Table Global Neurotherapeutic Drugs Revenue by Players (2012-2017) Table Global Neurotherapeutic Drugs Revenue Share (%) by Players (2012-2017) Figure 2016 Global Neurotherapeutic Drugs Revenue Share (%) by Players Figure 2017 Global Neurotherapeutic Drugs Revenue Share (%) by Players Table Global Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Global Neurotherapeutic Drugs Sales Share (%) by Type (2012-2017) Figure Sales Market Share (%) of Neurotherapeutic Drugs by Type (2012-2017) Figure Global Neurotherapeutic Drugs Sales Growth Rate by Type (2012-2017) Table Global Neurotherapeutic Drugs Revenue (Million USD) and Market Share (%) by Type (2012-2017) Table Global Neurotherapeutic Drugs Revenue Share (%) by Type (2012-2017) Figure Revenue Market Share (%) of Neurotherapeutic Drugs by Type (2012-2017) Figure Global Neurotherapeutic Drugs Revenue Growth Rate by Type (2012-2017) Table Global Neurotherapeutic Drugs Sales (K Units) and Market Share (%) by Regions (2012-2017) Table Global Neurotherapeutic Drugs Sales Share (%) by Regions (2012-2017) Figure Sales Market Share (%) of Neurotherapeutic Drugs by Regions (2012-2017) Figure Global Neurotherapeutic Drugs Sales Market Share (%) by Regions in 2017 Table Global Neurotherapeutic Drugs Revenue (Million USD) and Market Share (%) by Regions (2012-2017) Table Global Neurotherapeutic Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share (%) of Neurotherapeutic Drugs by Regions (2012-2017) Figure Global Neurotherapeutic Drugs Revenue Market Share (%) by Regions in 2017 Table Global Neurotherapeutic Drugs Sales (K Units) and Market Share (%) by Application (2012-2017) Table Global Neurotherapeutic Drugs Sales Share (%) by Application (2012-2017) Figure Sales Market Share (%) of Neurotherapeutic Drugs by Application (2012-2017) Figure Global Neurotherapeutic Drugs Sales Market Share (%) by Application (2012-2017) Figure North America Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure North America Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2017) Figure North America Neurotherapeutic Drugs Price (USD/Unit) Trend (2012-2017) Table North America Neurotherapeutic Drugs Sales (K Units) by Players (2012-2017) Table North America Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Players (2012-2017) Figure North America Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Players in 2017 Table North America Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table North America Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Type (2012-2017) Figure North America Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Type in 2017 Table North America Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table North America Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Applications (2012-2017) Figure North America Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Applications in 2017 Figure China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2017) Figure China Neurotherapeutic Drugs Price (USD/Unit) Trend (2012-2017) Table China Neurotherapeutic Drugs Sales (K Units) by Players (2012-2017) Table China Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Players (2012-2017) Figure China Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Players in 2017 Table China Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table China Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Type (2012-2017) Figure China Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Type in 2017 Table China Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table China Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Applications (2012-2017) Figure China Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Applications in 2017 Figure Europe Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Europe Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2017) Figure Europe Neurotherapeutic Drugs Price (USD/Unit) Trend (2012-2017) Table Europe Neurotherapeutic Drugs Sales (K Units) by Players (2012-2017) Table Europe Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Players (2012-2017) Figure Europe Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Players in 2017 Table Europe Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Europe Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Type (2012-2017) Figure Europe Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Type in 2017 Table Europe Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Europe Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Applications (2012-2017) Figure Europe Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Applications in 2017 Figure Japan Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Japan Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2017) Figure Japan Neurotherapeutic Drugs Price (USD/Unit) Trend (2012-2017) Table Japan Neurotherapeutic Drugs Sales (K Units) by Players (2012-2017) Table Japan Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Players (2012-2017) Figure Japan Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Players in 2017 Table Japan Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Japan Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Type (2012-2017) Figure Japan Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Type in 2017 Table Japan Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Japan Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Applications (2012-2017) Figure Japan Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Applications in 2017 Figure India Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure India Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2017) Figure India Neurotherapeutic Drugs Price (USD/Unit) Trend (2012-2017) Table India Neurotherapeutic Drugs Sales (K Units) by Players (2012-2017) Table India Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Players (2012-2017) Figure India Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Players in 2017 Table India Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table India Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Type (2012-2017) Figure India Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Type in 2017 Table India Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table India Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Applications (2012-2017) Figure India Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Applications in 2017 Figure Southeast Asia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Southeast Asia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2017) Figure Southeast Asia Neurotherapeutic Drugs Price (USD/Unit) Trend (2012-2017) Table Southeast Asia Neurotherapeutic Drugs Sales (K Units) by Players (2012-2017) Table Southeast Asia Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Players (2012-2017) Figure Southeast Asia Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Players in 2017 Table Southeast Asia Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Southeast Asia Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Type (2012-2017) Figure Southeast Asia Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Type in 2017 Table Southeast Asia Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Southeast Asia Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Applications (2012-2017) Figure Southeast Asia Neurotherapeutic Drugs Sales (K Units) Market Share (%) by Applications in 2017 Table Abbott Basic Information List Table Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Abbott Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table BD Basic Information List Table BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure BD Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure BD Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure BD Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Novartis AG Basic Information List Table Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Johnson & Johnson Basic Information List Table Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Pfizer Basic Information List Table Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Pfizer Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Sanofi-Aventis Basic Information List Table Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Biogen Basic Information List Table Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Biogen Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table AstraZeneca Merck Basic Information List Table AstraZeneca Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Merck Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure AstraZeneca Merck Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure AstraZeneca Merck Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Basic Information List Table Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Neurotherapeutic Drugs Sales Global Market Share (%) (2012-2017) Figure Neurotherapeutic Drugs Revenue Global Market Share (%) (2012-2017) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Neurotherapeutic Drugs Figure Manufacturing Process Analysis of Neurotherapeutic Drugs Figure Neurotherapeutic Drugs Industrial Chain Analysis Table Raw Materials Sources of Neurotherapeutic Drugs Major Players in 2017 Table Major Buyers of Neurotherapeutic Drugs Table Distributors/Traders List Figure Global Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Global Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure Global Neurotherapeutic Drugs Price (USD/Unit) and Trend Forecast (2018-2023) Table Global Neurotherapeutic Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure Global Neurotherapeutic Drugs Sales (K Units) Market Share (%) Forecast by Regions (2018-2023) Figure Global Neurotherapeutic Drugs Sales (K Units) Market Share (%) Forecast by Regions in 2023 Table Global Neurotherapeutic Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Neurotherapeutic Drugs Revenue Market Share (%) Forecast by Regions (2018-2023) Figure Global Neurotherapeutic Drugs Revenue Market Share (%) Forecast by Regions in 2023 Figure North America Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North America Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure Europe Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Europe Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure China Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure Japan Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure Southeast Asia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Figure India Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2023) Table Global Neurotherapeutic Drugs Sales Forecast by Type (2018-2023) Figure Global Neurotherapeutic Drugs Sales Market Share (%) Forecast by Type (2018-2023) Table Global Neurotherapeutic Drugs Revenue Forecast by Type (2018-2023) Figure Global Neurotherapeutic Drugs Revenue Market Share (%) Forecast by Type (2018-2023) Table Global Neurotherapeutic Drugs Price Forecast by Type (2018-2023) Table Global Neurotherapeutic Drugs Sales Forecast by Application (2018-2023) Figure Global Neurotherapeutic Drugs Sales Market Share (%) Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott BD Novartis AG Johnson & Johnson Pfizer Sanofi-Aventis Biogen GlaxoSmithKline AstraZeneca Merck